Two years ago, the TruNews team was in Davos Switzerland as guests of the Trump White House to attend the 2020 World Economic Forum from January 20 to Jan 24. Weeks earlier we reported for the first time about rumors of a coronavirus outbreak in China. We were nervous in Davos as we witnessed members of the Chinese delegation coughing among the world dignitaries. Months earlier – October 18, 2019 – the Johns Hopkins Center for Health Security in partnership with the World Economic Forum and the Bill and Melinda Gates Foundation hosted Event 201, a high-level pandemic exercise that involved a coronavirus. What a coincidence that weeks after the Bill Gates event, coronavirus infections started in China.
@ 11:48 of the video: Monkeypox 1st discovered 1958 in monkeys being kept for research.
ECDC source tells me that the preliminary analysis of monkeypox indicates that it is “a third lab strain with unknown characteristics” and that there is chatter about this being somehow related to Moscow’s charges against U.S. biological activities in Ukraine.
Strengthening Global Systems to Prevent and Respond to High Consequence Biological Threats
Nov 23, 2021
Nuclear Threat Initiative
In March 2021, NTI partnered with the Munich Security Conference to conduct a tabletop exercise on reducing high-consequence biological threats. The exercise examined gaps in national and international biosecurity and pandemic preparedness architectures—exploring opportunities to improve prevention and response capabilities for high-consequence biological events. Participants included 19 senior leaders and experts from across Africa, the Americas, Asia, and Europe with decades of combined experience in public health, biotechnology industry, international security, and philanthropy.
This report, "Strengthening Global Systems to Prevent and Respond to High-Consequence Biological Threats: Results from the 2021 Tabletop Exercise Conducted in Partnership with the Munich Security Conference," written by Jaime M. Yassif, Ph.D., Kevin P. O’Prey, Ph.D., and Christopher R. Isaac, M.Sc., summarizes key findings from the exercise and offers actionable recommendations for the international community.
The report launch on November 23, 2021 was chaired by NTI | bio Interim Vice President Dr. Margaret A. Hamburg and featured remarks from Twist Biosciences CEO and Co-Founder Dr. Emily Leproust, and NTI | bio Senior Fellow Dr. Jaime Yassif.